MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


0026-895X/04/6503-646-654$20.00
Mol Pharmacol 65:646-654, 2004

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Raouf, R.
Right arrow Articles by Séguéla, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Raouf, R.
Right arrow Articles by Séguéla, P.

Selective Knock-Down of P2X7 ATP Receptor Function by Dominant-Negative Subunits

Ramin Raouf, Yassar Chakfe, Dominique Blais, Audrey Speelman, Eric Boué-Grabot, Duncan Henderson, and Philippe Séguéla

Montreal Neurological Institute, Department of Neurology and Neurosurgery, McGill University, Montreal, Quebec, Canada (R.R., Y.C., D.B., A.S., P.S.); Unité Mixte de Recherche 5543, Centre National de la Recherche Scientifique, Université Victor Segalen Bordeaux 2, Bordeaux, France (E.B.-G.); and AstraZeneca R&D Charnwood, Loughborough, England (D.H.)

Among the family of P2X ATP-gated cation channels, the P2X7 receptor is a homomeric subtype highly expressed in immune cells of the monocyte-macrophage lineage. We report here that the WC167-168AA mutation in the ectodomain of P2X7 produced nonfunctional subunits with strong dominant-negative effect on wild-type P2X7 receptors (77% inhibition with cotransfection of wild-type and mutant DNA at a ratio of 3:1). The C168A single mutant was also very effective in suppressing P2X7 receptor function (72% reduction at a DNA ratio of 3:1), indicating the major role played by the C168A mutation in this inhibition. The dominant-negative effect is selective; the mutant subunit did not suppress the function of other receptor-channel subtypes. The reduced current responses in cells coexpressing wild-type and dominant-negative subunits display wild-type characteristics in both agonist affinity and ionic selectivity, strongly suggesting that the heteromeric channels are functionally impaired. The mutant subunits also suppressed the P2X7-dependent pore formation as assessed by uptake of the propidium dye YO-PRO-1 (Molecular Probes, Eugene, OR) in response to 2',3'-O-(4-benzoyl)-benzoyl-ATP (BzATP) in transfected human embryonic kidney 293 cells. Native responses to BzATP as well as ATP-induced ethidium dye uptake were significantly knocked down (31 ± 9% and 25 ± 7% of control, respectively) in mouse macrophage cell line RAW264.7 transfected with the mutant subunits. Therefore, these dominant-negative subunits provide selective genetic tools to investigate the functional roles of native P2X7 receptors.


Received July 1, 2003; accepted November 21, 2003

Address correspondence to: Dr. Philippe Séguéla, Montreal Neurological Institute, 3801 University Street, Suite 778, Montreal, QC, Canada, H3A 2B4. E-mail: philippe.seguela{at}mcgill.ca




This article has been cited by other articles:


Home page
Am. J. Physiol. Cell Physiol.Home page
Z.-Z. Mei, H.-J. Mao, and L.-H. Jiang
Conserved cysteine residues in the pore region are obligatory for human TRPM2 channel function
Am J Physiol Cell Physiol, November 1, 2006; 291(5): C1022 - C1028.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2004 by the American Society for Pharmacology and Experimental Therapeutics